Aptevo Therapeutics names Mary Janatpour senior vice president, chief scientific officer

Aptevo Therapeutics, Inc.

Aptevo Therapeutics, Inc.

APVO

0.00
  • Aptevo appointed Mary J. Janatpour as senior vice president, chief scientific officer to lead research, preclinical development, pipeline strategy.
  • She brings over 25 years of oncology R&D leadership across biotech, pharma, spanning target discovery, translational science, immuno-oncology.
  • Previously held leadership roles at Novartis Institutes for Biomedical Research, Schering-Plough Biopharma, Chiron, focused on oncology biologics targets.
  • Appointment supports a clinical focus on mipletamig, an expanding multispecific oncology pipeline, a radiopharmaceutical strategy tied to Niowave collaboration.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptevo Therapeutics Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202605280805ACCESSWRNAPR_____1171339) on May 28, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.